Bilcare Technologies has launched its nonClonable patient safety system in the U.S. to help prevent counterfeit drugs and enhance patient compliance. The nonClonable system is designed to ensure the authenticity of medicines, secure the supply chain, and provide validation. “Counterfeit drug sales will reach $75 billion globally in 2010, an increase of more than 90% from 2005 as indicated by the U.S.-based Centre for Medicines in the Public Interest and the World Health Organization. Bilcare&...